Therapeutic Nuclear Medicines Market Insights: Global Market Drivers, Restraints, Covid-19 Impact Analysis, Opportunities, Applications, Trends And Forecast 2020-2026

1 Study Coverage
1.1 Therapeutic Nuclear Medicines Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type
1.4.2 Radium-223
1.4.3 Lutetium-177
1.4.4 Iodine-131
1.4.5 Other
1.5 Market by Application
1.5.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application
1.5.2 Thyroid
1.5.3 Bone Metastasis
1.5.4 Lymphoma
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Therapeutic Nuclear Medicines Industry Impact
1.6.1 How the Covid-19 is Affecting the Therapeutic Nuclear Medicines Industry
1.6.1.1 Therapeutic Nuclear Medicines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Therapeutic Nuclear Medicines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Therapeutic Nuclear Medicines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Therapeutic Nuclear Medicines Market Size Estimates and Forecasts
2.1.1 Global Therapeutic Nuclear Medicines Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Therapeutic Nuclear Medicines Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Therapeutic Nuclear Medicines Production Estimates and Forecasts 2015-2026
2.2 Global Therapeutic Nuclear Medicines Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Therapeutic Nuclear Medicines Manufacturers Geographical Distribution
2.4 Key Trends for Therapeutic Nuclear Medicines Markets & Products
2.5 Primary Interviews with Key Therapeutic Nuclear Medicines Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Production Capacity
3.1.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Therapeutic Nuclear Medicines Manufacturers by Production (2015-2020)
3.1.3 Global Top Therapeutic Nuclear Medicines Manufacturers Market Share by Production
3.2 Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue
3.2.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Therapeutic Nuclear Medicines Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Medicines Revenue in 2019
3.3 Global Therapeutic Nuclear Medicines Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Nuclear Medicines Production by Regions
4.1 Global Therapeutic Nuclear Medicines Historic Market Facts & Figures by Regions
4.1.1 Global Top Therapeutic Nuclear Medicines Regions by Production (2015-2020)
4.1.2 Global Top Therapeutic Nuclear Medicines Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Therapeutic Nuclear Medicines Production (2015-2020)
4.2.2 North America Therapeutic Nuclear Medicines Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Therapeutic Nuclear Medicines Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Therapeutic Nuclear Medicines Production (2015-2020)
4.3.2 Europe Therapeutic Nuclear Medicines Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Therapeutic Nuclear Medicines Import & Export (2015-2020)
4.4 China
4.4.1 China Therapeutic Nuclear Medicines Production (2015-2020)
4.4.2 China Therapeutic Nuclear Medicines Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Therapeutic Nuclear Medicines Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Therapeutic Nuclear Medicines Production (2015-2020)
4.5.2 Japan Therapeutic Nuclear Medicines Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Therapeutic Nuclear Medicines Import & Export (2015-2020)
5 Therapeutic Nuclear Medicines Consumption by Region
5.1 Global Top Therapeutic Nuclear Medicines Regions by Consumption
5.1.1 Global Top Therapeutic Nuclear Medicines Regions by Consumption (2015-2020)
5.1.2 Global Top Therapeutic Nuclear Medicines Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Therapeutic Nuclear Medicines Consumption by Application
5.2.2 North America Therapeutic Nuclear Medicines Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Therapeutic Nuclear Medicines Consumption by Application
5.3.2 Europe Therapeutic Nuclear Medicines Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Therapeutic Nuclear Medicines Consumption by Application
5.4.2 Asia Pacific Therapeutic Nuclear Medicines Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Therapeutic Nuclear Medicines Consumption by Application
5.5.2 Central & South America Therapeutic Nuclear Medicines Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Therapeutic Nuclear Medicines Consumption by Application
5.6.2 Middle East and Africa Therapeutic Nuclear Medicines Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 UAE
6 Market Size by Type (2015-2026)
6.1 Global Therapeutic Nuclear Medicines Market Size by Type (2015-2020)
6.1.1 Global Therapeutic Nuclear Medicines Production by Type (2015-2020)
6.1.2 Global Therapeutic Nuclear Medicines Revenue by Type (2015-2020)
6.1.3 Therapeutic Nuclear Medicines Price by Type (2015-2020)
6.2 Global Therapeutic Nuclear Medicines Market Forecast by Type (2021-2026)
6.2.1 Global Therapeutic Nuclear Medicines Production Forecast by Type (2021-2026)
6.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2021-2026)
6.2.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2021-2026)
6.3 Global Therapeutic Nuclear Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Therapeutic Nuclear Medicines Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 Bayer
8.1.1 Bayer Corporation Information
8.1.2 Bayer Overview and Its Total Revenue
8.1.3 Bayer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Bayer Product Description
8.1.5 Bayer Recent Development
8.2 Novartis AG
8.2.1 Novartis AG Corporation Information
8.2.2 Novartis AG Overview and Its Total Revenue
8.2.3 Novartis AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Novartis AG Product Description
8.2.5 Novartis AG Recent Development
8.3 China Isotope & Radiation
8.3.1 China Isotope & Radiation Corporation Information
8.3.2 China Isotope & Radiation Overview and Its Total Revenue
8.3.3 China Isotope & Radiation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 China Isotope & Radiation Product Description
8.3.5 China Isotope & Radiation Recent Development
8.4 Dongcheng
8.4.1 Dongcheng Corporation Information
8.4.2 Dongcheng Overview and Its Total Revenue
8.4.3 Dongcheng Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Dongcheng Product Description
8.4.5 Dongcheng Recent Development
8.5 Q BioMed
8.5.1 Q BioMed Corporation Information
8.5.2 Q BioMed Overview and Its Total Revenue
8.5.3 Q BioMed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Q BioMed Product Description
8.5.5 Q BioMed Recent Development
8.6 Curium Pharmaceuticals
8.6.1 Curium Pharmaceuticals Corporation Information
8.6.2 Curium Pharmaceuticals Overview and Its Total Revenue
8.6.3 Curium Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Curium Pharmaceuticals Product Description
8.6.5 Curium Pharmaceuticals Recent Development
8.7 Jubilant DraxImage
8.7.1 Jubilant DraxImage Corporation Information
8.7.2 Jubilant DraxImage Overview and Its Total Revenue
8.7.3 Jubilant DraxImage Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Jubilant DraxImage Product Description
8.7.5 Jubilant DraxImage Recent Development
8.8 Lantheus
8.8.1 Lantheus Corporation Information
8.8.2 Lantheus Overview and Its Total Revenue
8.8.3 Lantheus Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Lantheus Product Description
8.8.5 Lantheus Recent Development
8.9 Spectrum Pharmaceuticals
8.9.1 Spectrum Pharmaceuticals Corporation Information
8.9.2 Spectrum Pharmaceuticals Overview and Its Total Revenue
8.9.3 Spectrum Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Spectrum Pharmaceuticals Product Description
8.9.5 Spectrum Pharmaceuticals Recent Development
8.10 Progenics Pharmaceuticals
8.10.1 Progenics Pharmaceuticals Corporation Information
8.10.2 Progenics Pharmaceuticals Overview and Its Total Revenue
8.10.3 Progenics Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Progenics Pharmaceuticals Product Description
8.10.5 Progenics Pharmaceuticals Recent Development
8.11 International Isotopes
8.11.1 International Isotopes Corporation Information
8.11.2 International Isotopes Overview and Its Total Revenue
8.11.3 International Isotopes Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 International Isotopes Product Description
8.11.5 International Isotopes Recent Development
9 Production Forecasts by Regions
9.1 Global Top Therapeutic Nuclear Medicines Regions Forecast by Revenue (2021-2026)
9.2 Global Top Therapeutic Nuclear Medicines Regions Forecast by Production (2021-2026)
9.3 Key Therapeutic Nuclear Medicines Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Therapeutic Nuclear Medicines Consumption Forecast by Region
10.1 Global Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026)
10.2 North America Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026)
10.3 Europe Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026)
10.5 Latin America Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Therapeutic Nuclear Medicines Sales Channels
11.2.2 Therapeutic Nuclear Medicines Distributors
11.3 Therapeutic Nuclear Medicines Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Therapeutic Nuclear Medicines Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Table
List of Tables
Table 1. Therapeutic Nuclear Medicines Key Market Segments in This Study
Table 2. Ranking of Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Radium-223
Table 5. Major Manufacturers of Lutetium-177
Table 6. Major Manufacturers of Iodine-131
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Therapeutic Nuclear Medicines Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Therapeutic Nuclear Medicines Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Therapeutic Nuclear Medicines Players to Combat Covid-19 Impact
Table 13. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Therapeutic Nuclear Medicines Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Medicines as of 2019)
Table 17. Therapeutic Nuclear Medicines Manufacturing Base Distribution and Headquarters
Table 18. Manufacturers Therapeutic Nuclear Medicines Product Offered
Table 19. Date of Manufacturers Enter into Therapeutic Nuclear Medicines Market
Table 20. Key Trends for Therapeutic Nuclear Medicines Markets & Products
Table 21. Main Points Interviewed from Key Therapeutic Nuclear Medicines Players
Table 22. Global Therapeutic Nuclear Medicines Production Capacity by Manufacturers (2015-2020) (K Units)
Table 23. Global Therapeutic Nuclear Medicines Production Share by Manufacturers (2015-2020)
Table 24. Therapeutic Nuclear Medicines Revenue by Manufacturers (2015-2020) (Million US$)
Table 25. Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)
Table 26. Therapeutic Nuclear Medicines Price by Manufacturers 2015-2020 (USD/Unit)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Therapeutic Nuclear Medicines Production by Regions (2015-2020) (K Units)
Table 29. Global Therapeutic Nuclear Medicines Production Market Share by Regions (2015-2020)
Table 30. Global Therapeutic Nuclear Medicines Revenue by Regions (2015-2020) (US$ Million)
Table 31. Global Therapeutic Nuclear Medicines Revenue Market Share by Regions (2015-2020)
Table 32. Key Therapeutic Nuclear Medicines Players in North America
Table 33. Import & Export of Therapeutic Nuclear Medicines in North America (K Units)
Table 34. Key Therapeutic Nuclear Medicines Players in Europe
Table 35. Import & Export of Therapeutic Nuclear Medicines in Europe (K Units)
Table 36. Key Therapeutic Nuclear Medicines Players in China
Table 37. Import & Export of Therapeutic Nuclear Medicines in China (K Units)
Table 38. Key Therapeutic Nuclear Medicines Players in Japan
Table 39. Import & Export of Therapeutic Nuclear Medicines in Japan (K Units)
Table 40. Global Therapeutic Nuclear Medicines Consumption by Regions (2015-2020) (K Units)
Table 41. Global Therapeutic Nuclear Medicines Consumption Market Share by Regions (2015-2020)
Table 42. North America Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)
Table 43. North America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)
Table 44. Europe Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)
Table 45. Europe Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)
Table 46. Asia Pacific Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)
Table 47. Asia Pacific Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020) (K Units)
Table 48. Asia Pacific Therapeutic Nuclear Medicines Consumption by Regions (2015-2020) (K Units)
Table 49. Latin America Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)
Table 50. Latin America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)
Table 51. Middle East and Africa Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)
Table 52. Middle East and Africa Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)
Table 53. Global Therapeutic Nuclear Medicines Production by Type (2015-2020) (K Units)
Table 54. Global Therapeutic Nuclear Medicines Production Share by Type (2015-2020)
Table 55. Global Therapeutic Nuclear Medicines Revenue by Type (2015-2020) (Million US$)
Table 56. Global Therapeutic Nuclear Medicines Revenue Share by Type (2015-2020)
Table 57. Therapeutic Nuclear Medicines Price by Type 2015-2020 (USD/Unit)
Table 58. Global Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)
Table 59. Global Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units)
Table 60. Global Therapeutic Nuclear Medicines Consumption Share by Application (2015-2020)
Table 61. Bayer Corporation Information
Table 62. Bayer Description and Major Businesses
Table 63. Bayer Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 64. Bayer Product
Table 65. Bayer Recent Development
Table 66. Novartis AG Corporation Information
Table 67. Novartis AG Description and Major Businesses
Table 68. Novartis AG Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. Novartis AG Product
Table 70. Novartis AG Recent Development
Table 71. China Isotope & Radiation Corporation Information
Table 72. China Isotope & Radiation Description and Major Businesses
Table 73. China Isotope & Radiation Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. China Isotope & Radiation Product
Table 75. China Isotope & Radiation Recent Development
Table 76. Dongcheng Corporation Information
Table 77. Dongcheng Description and Major Businesses
Table 78. Dongcheng Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Dongcheng Product
Table 80. Dongcheng Recent Development
Table 81. Q BioMed Corporation Information
Table 82. Q BioMed Description and Major Businesses
Table 83. Q BioMed Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Q BioMed Product
Table 85. Q BioMed Recent Development
Table 86. Curium Pharmaceuticals Corporation Information
Table 87. Curium Pharmaceuticals Description and Major Businesses
Table 88. Curium Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Curium Pharmaceuticals Product
Table 90. Curium Pharmaceuticals Recent Development
Table 91. Jubilant DraxImage Corporation Information
Table 92. Jubilant DraxImage Description and Major Businesses
Table 93. Jubilant DraxImage Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Jubilant DraxImage Product
Table 95. Jubilant DraxImage Recent Development
Table 96. Lantheus Corporation Information
Table 97. Lantheus Description and Major Businesses
Table 98. Lantheus Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Lantheus Product
Table 100. Lantheus Recent Development
Table 101. Spectrum Pharmaceuticals Corporation Information
Table 102. Spectrum Pharmaceuticals Description and Major Businesses
Table 103. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Spectrum Pharmaceuticals Product
Table 105. Spectrum Pharmaceuticals Recent Development
Table 106. Progenics Pharmaceuticals Corporation Information
Table 107. Progenics Pharmaceuticals Description and Major Businesses
Table 108. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Progenics Pharmaceuticals Product
Table 110. Progenics Pharmaceuticals Recent Development
Table 111. International Isotopes Corporation Information
Table 112. International Isotopes Description and Major Businesses
Table 113. International Isotopes Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. International Isotopes Product
Table 115. International Isotopes Recent Development
Table 116. Global Therapeutic Nuclear Medicines Revenue Forecast by Region (2021-2026) (Million US$)
Table 117. Global Therapeutic Nuclear Medicines Production Forecast by Regions (2021-2026) (K Units)
Table 118. Global Therapeutic Nuclear Medicines Production Forecast by Type (2021-2026) (K Units)
Table 119. Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2021-2026) (Million US$)
Table 120. North America Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units)
Table 121. Europe Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units)
Table 122. Asia Pacific Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units)
Table 123. Latin America Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units)
Table 124. Middle East and Africa Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units)
Table 125. Therapeutic Nuclear Medicines Distributors List
Table 126. Therapeutic Nuclear Medicines Customers List
Table 127. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 128. Key Challenges
Table 129. Market Risks
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Fifures
Figure 1. Therapeutic Nuclear Medicines Product Picture
Figure 2. Global Therapeutic Nuclear Medicines Production Market Share by Type in 2020 & 2026
Figure 3. Radium-223 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Iodine-131 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Therapeutic Nuclear Medicines Consumption Market Share by Application in 2020 & 2026
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Therapeutic Nuclear Medicines Report Years Considered
Figure 13. Global Therapeutic Nuclear Medicines Revenue 2015-2026 (Million US$)
Figure 14. Global Therapeutic Nuclear Medicines Production Capacity 2015-2026 (K Units)
Figure 15. Global Therapeutic Nuclear Medicines Production 2015-2026 (K Units)
Figure 16. Global Therapeutic Nuclear Medicines Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 17. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Therapeutic Nuclear Medicines Production Share by Manufacturers in 2015
Figure 19. The Top 10 and Top 5 Players Market Share by Therapeutic Nuclear Medicines Revenue in 2019
Figure 20. Global Therapeutic Nuclear Medicines Production Market Share by Region (2015-2020)
Figure 21. Therapeutic Nuclear Medicines Production Growth Rate in North America (2015-2020) (K Units)
Figure 22. Therapeutic Nuclear Medicines Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 23. Therapeutic Nuclear Medicines Production Growth Rate in Europe (2015-2020) (K Units)
Figure 24. Therapeutic Nuclear Medicines Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 25. Therapeutic Nuclear Medicines Production Growth Rate in China (2015-2020) (K Units)
Figure 26. Therapeutic Nuclear Medicines Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 27. Therapeutic Nuclear Medicines Production Growth Rate in Japan (2015-2020) (K Units)
Figure 28. Therapeutic Nuclear Medicines Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 29. Global Therapeutic Nuclear Medicines Consumption Market Share by Regions 2015-2020
Figure 30. North America Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. North America Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019
Figure 32. North America Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019
Figure 33. U.S. Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Canada Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Europe Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019
Figure 37. Europe Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019
Figure 38. Germany Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. France Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. U.K. Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Italy Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Russia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Asia Pacific Therapeutic Nuclear Medicines Consumption and Growth Rate (K Units)
Figure 44. Asia Pacific Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019
Figure 45. Asia Pacific Therapeutic Nuclear Medicines Consumption Market Share by Regions in 2019
Figure 46. China Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Japan Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. India Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Australia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Thailand Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Malaysia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Philippines Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Vietnam Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Latin America Therapeutic Nuclear Medicines Consumption and Growth Rate (K Units)
Figure 58. Latin America Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019
Figure 59. Latin America Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019
Figure 60. Mexico Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Brazil Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Argentina Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Middle East and Africa Therapeutic Nuclear Medicines Consumption and Growth Rate (K Units)
Figure 64. Middle East and Africa Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019
Figure 65. Middle East and Africa Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019
Figure 66. Turkey Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Saudi Arabia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. UAE Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. Global Therapeutic Nuclear Medicines Production Market Share by Type (2015-2020)
Figure 70. Global Therapeutic Nuclear Medicines Production Market Share by Type in 2019
Figure 71. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2015-2020)
Figure 72. Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2019
Figure 73. Global Therapeutic Nuclear Medicines Production Market Share Forecast by Type (2021-2026)
Figure 74. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2021-2026)
Figure 75. Global Therapeutic Nuclear Medicines Market Share by Price Range (2015-2020)
Figure 76. Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)
Figure 77. Global Therapeutic Nuclear Medicines Value (Consumption) Market Share by Application (2015-2020)
Figure 78. Global Therapeutic Nuclear Medicines Consumption Market Share Forecast by Application (2021-2026)
Figure 79. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Q BioMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Curium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Jubilant DraxImage Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Spectrum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Progenics Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. International Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Global Therapeutic Nuclear Medicines Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 91. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Regions ((2021-2026))
Figure 92. Global Therapeutic Nuclear Medicines Production Forecast by Regions (2021-2026) (K Units)
Figure 93. North America Therapeutic Nuclear Medicines Production Forecast (2021-2026) (K Units)
Figure 94. North America Therapeutic Nuclear Medicines Revenue Forecast (2021-2026) (US$ Million)
Figure 95. Europe Therapeutic Nuclear Medicines Production Forecast (2021-2026) (K Units)
Figure 96. Europe Therapeutic Nuclear Medicines Revenue Forecast (2021-2026) (US$ Million)
Figure 97. China Therapeutic Nuclear Medicines Production Forecast (2021-2026) (K Units)
Figure 98. China Therapeutic Nuclear Medicines Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Japan Therapeutic Nuclear Medicines Production Forecast (2021-2026) (K Units)
Figure 100. Japan Therapeutic Nuclear Medicines Revenue Forecast (2021-2026) (US$ Million)
Figure 101. Global Therapeutic Nuclear Medicines Consumption Market Share Forecast by Region (2021-2026)
Figure 102. Therapeutic Nuclear Medicines Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed